2019 · Clinical pharmacology and therapeutics · open access
Leveraging Digital Health Technologies and Outpatient Sampling in Clinical Drug Development: A Phase I Exploratory Study
Dockendorf et al.
The finding, in our words
In a fixed-sequence two-period Phase I study of 16 healthy volunteers taking sitagliptin, dried blood spot samples collected at home and digital adherence data captured via an electronic pill bottle were feasible and acceptable to participants. This supports patient-centric microsampling and remote monitoring for decentralised clinical trials, though the authors noted areas needing improvement.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.